Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(50.0%)
N/A
3(50.0%)
6Total
Phase 4(3)
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07167342Phase 4Not Yet Recruiting

The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma

Role: collaborator

NCT07152886Phase 4Not Yet Recruiting

The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer

Role: collaborator

NCT05352802Not ApplicableActive Not Recruiting

Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer

Role: collaborator

NCT05901779Not ApplicableUnknown

Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy

Role: collaborator

NCT04636099Not ApplicableUnknown

Gastrointestinal Surgery Study Group 2001

Role: collaborator

NCT03510832Unknown

Evaluation of Antithrombotic STrategies in STEMI Patients in China

Role: collaborator

NCT02550080Phase 4Unknown

Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome

Role: collaborator

All 7 trials loaded